|
Galena Biopharma (originally RXi Pharmaceuticals) is a publicly traded pharmaceutical company based in San Ramon, California. The company was founded in Worcester, Massachusetts. In 2011, it moved to Oregon, and in 2015 moved to San Ramon, California. Mark Schwartz is the company's president and chief executive officer.〔(【引用サイトリンク】 title=Ownership of Securities )〕 ==History== In November 2006, Argonaut Pharmaceuticals, Inc. changed the name to RXi Pharmaceuticals Corporation.〔 RXi was a subsidiary of CytRx Corp., which provided $15 million in financing in April 2007. RXi was founded in part by Nobel Prize winner Craig Mello.〔 In September 2007, RXi signed a licensing deal with TriLink Biotechnologies, a competitor in the RNA interference (RNAi) field, in which RXi would pay TriLink to use three of TriLink's technologies.〔 RXi went public in March 2008. CytRx retained 49% ownership of RXi's stock and gave shares of RXi to existing shareholders. Trading began on the NASDAQ market on March 12, 2008, under the ticker symbol of RXII. Fidelity Investments invested $8.5 million in the company in May 2008, followed by a $25 million private-equity investment by Yorkville in February 2009. In 2010, RXi received a National Institutes of Health grant of $600,000. By August 2010, the company had 30 employees.〔 In March 2011, president and CEO Noah Beerman was replaced by Mark Ahn. The same month, the company announced the planned acquisition of Arizona-based Apthera, Inc. for $7 million. The acquisition included the breast cancer drug NeuVax. In April 2011, RXi raised about $12 million from a stock offering and received $580,000 in grants from the National Institutes of Health. In June 2011, NeuVax was approved by the United States Food and Drug Administration to start a stage three clinical trial. In September 2011, the company separated its cancer therapies division. It was renamed Galena Biopharma Inc and moved to Lake Oswego, Oregon.〔〔 RXi became a subsidiary of Galena and retained RNAi technologies.〔 RXi Pharmaceuticals remained in Massachusetts as a publicly traded company.〔 In October 2011, Galena restated their financial results. In November 2011, the company partnered with Genentech to combine drugs from each company for a cancer treatment. The company reported a loss of $11.5 million loss for 2011. In November 2012, an anonymous internet report caused Galena stock to decline. The company filed a lawsuit claiming the report was false and attempted to manipulate the stock. In 2013 Galena began selling its first drug, an analgesic for cancer pain named Abstral Sublingual.〔 In January 2014, Galena bought Mills Pharmaceuticals. In April 2014, the company headquarters moved to Portland. In August 2014, CEO Mark Ahn resigned and was replaced by Mark Schwartz.〔〔 In 2014, Galena was involved in a stock promotion scheme. Galena paid The DreamTeam Group $50,000 to write at least five promotional articles that appeared on Seeking Alpha. The articles carried no conflict of interest disclosure and were written by several pseudonyms. The stock price increased and insiders sold hundred of thousands of shares. Galena disclosed the relationship with The DreamTeam Group to the SEC. By March 2014, five lawsuits were filed against Galena and several of its officers alleging that the company used misleading articles to boost stock prices.〔〔 Motley Fool, discussing the 23% stock price drop during March 2015, noted there was stock dilution from the offering and also that Astral's sales were below Galena's estimates from late 2013. Discussing the Motley Fool article, Portland Business Journal also noted the ongoing insider-trading lawsuits as a factor in the stock price. A few days later, Zacks Investment Research said Galena could be a "great candidate" to beat its earnings. In response, Galena's CEO said there were many positive aspects to the company, and that the lawsuits weren't a worry as they should get covered under Directors and officers liability insurance. The company moved to San Ramon, California, in the Bay Area in 2015.〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Galena Biopharma」の詳細全文を読む スポンサード リンク
|